Q3CY26 Quarterly Result - Sanofi Consumer

SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Q3CY26 Quarterly Result Announced for Sanofi Consumer Healthcare India Ltd. Pharmaceuticals company Sanofi Consumer Healthcare India announced Q3CY26 results Financial Highlights: Revenue from operations: For Q3CY26, revenue from operations stood at Rs 2,631 million, showing an increase of 11.62% QoQ from Rs 2,357 million in Q2CY26 and a growth of 12.48% YoY compared to Rs 2,339 million in Q3CY25. For 9MCY26, revenue from operations reached Rs 7,280 million compared to Rs 6,274 million in 9MCY25. Total income: For Q3CY26, total income stood at Rs 2,675 million, showing a QoQ growth of 10.54% from Rs 2,420 million in Q2CY26 and a YoY increase of 12.92% from Rs 2,369 million in Q3CY25. For 9MCY26, total income reached Rs 7,443 million compared to Rs 6,412 million in 9MCY25. Profit before tax (PBT): For Q3CY26, profit before tax stood at Rs 1,027 million, growing by 11.75% QoQ from Rs 919 million in Q2CY26 and by 22.12% YoY from Rs 841 million in Q3CY25. For 9MCY26, profit before tax was Rs 2,853 million compared to Rs 2,298 million in 9MCY25. Net profit after tax (PAT): For Q3CY26, profit for the period stood at Rs 766 million, showing an 11.34% QoQ expansion from Rs 688 million in Q2CY26 and a 21.78% YoY increase from Rs 629 million in Q3CY25. For 9MCY26 (nine-month period listed), profit after tax was Rs 2,132 million compared to Rs 1,736 million in 9MCY25. Earnings per share (EPS): For Q3CY26, basic and diluted EPS stood at Rs 33.26, increasing by 11.35% QoQ from Rs 29.87 in Q2CY26 and by 21.79% YoY from Rs 27.31 in Q3CY25. For 9MCY26, basic and diluted EPS stood at Rs 92.57 compared to Rs 75.38 in 9MCY25. All this is for information This is not a buy/sell recommendation. SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Thank you, Technofunda24